SP
FRLN

Syncona Portfolio’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Syncona Portfolio’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,466,507
Closed -$9.33M – 4
2023
Q4 		$9.33M Hold
1,466,507
– – 5.91% 3
2023
Q3 		$6.22M Sell
1,466,507
-1
-0% -$4 9.26% 3
2023
Q2 		$3.78M Hold
1,466,508
– – 5.7% 3
2023
Q1 		$10.1M Hold
1,466,508
– – 16.45% 3
2022
Q4 		$10.5M Hold
1,466,508
– – 16.59% 2
2022
Q3 		$15.3M Hold
1,466,508
– – 26.56% 3
2022
Q2 		$19.3M Hold
1,466,508
– – 27.43% 3
2022
Q1 		$5.84M Buy
1,466,508
+1,269,841
+646% +$23.6M 5.58% 3
2021
Q4 		$5.84M Buy
+196,667
New +$8.03M 5.58% 3

Syncona Portfolio's FRLN Position: Q1 2024 in Review

Syncona Portfolio sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2024, closing a stake of 1,466,507 shares — an estimated $9.33M sold.

Syncona Portfolio first reported a position in FRLN in Q4 2021 and held it in 9 quarters. The position peaked at $19.3M in Q2 2022. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.

  • Syncona Portfolio reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Syncona Portfolio sold 1,466,507 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2024, an estimated $9.33M.
  • Syncona Portfolio first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q4 2021 and held it in 9 quarters.
  • Syncona Portfolio's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $19.3M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2024.

Based on Syncona Portfolio's 13F filing for Q1 2024, filed 7 May 2024.